Patent details

Basic Information

Publication number:

92057

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP009746678

Legal Status:

Active

Application number:

92057

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/11/749/001-002

Marketing Authorization Type:

Marketing Authorization Date:

17/02/2012

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

07/08/2012

First Marketing Authorization date:

17/02/2012

Grant date:

08/10/2012

Activation date:

01/11/2020

Publication date:

08/10/2012

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

01/11/2025

SPC Extension Expiration:

01/11/2025

Rejection date:

Withdrawal date:

Owner

From:

03/11/2016

 

 

Name:

GENZYME CORPORATION

Address:

KENDALL STREET 500, CAMBRIDGE, MA 02142, United States (US)

History of Owners

From:

07/08/2012

To:

02/11/2016

Name:

ASTRAZENECA AB

Address:

VÄSTRA MÄLAREHAMNEN 9, 151 85, SÖDERTÄLJE, Sweden (SE)

Agent

Name:

ARONOVA S.A.

From:

07/08/2012

Address:

PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

Hennequin Laurent François André

Address:

France (FR)

2

Name:

Stokes Elaine Sophie Elizabeth

Address:

United Kingdom (GB)

3

Name:

Thomas Andrew Peter

Address:

United Kingdom (GB)

Publication

Bulletin

Bulletin Heading:

SPC3

Bulletin edition number:

2020/13

Publication date:

07/12/2020

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

25/10/2024

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages